George L. Mulvey

2.9k citations

42 papers · 2.3k indexed · 1 hit paper · h-index 25

Co-authors: Glen D. Armstrong Pavel I. Kitov David R. Bundle Joanna Sadowska Randy J. Read Hong Ling N.S. Pannu Paola Marcato
Topics: Escherichia coli research studies (28 papers)Viral gastroenteritis research and epidemiology (14 papers)Clostridium difficile and Clostridium perfringens research (13 papers)
Cited by: Endocrinology Infectious Diseases Molecular Medicine
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Canada United States United Kingdom

In The Last Decade

George L. Mulvey

42 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands

2000 713 citations Pavel I. Kitov, Joanna Sadowska et al. Nature profile →

Peers

Countries citing papers authored by George L. Mulvey

Since Specialization

Citations

This map shows the geographic impact of George L. Mulvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George L. Mulvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George L. Mulvey more than expected).

Fields of papers citing papers by George L. Mulvey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George L. Mulvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George L. Mulvey. The network helps show where George L. Mulvey may publish in the future.

Co-authorship network of co-authors of George L. Mulvey

This figure shows the co-authorship network connecting the top 25 collaborators of George L. Mulvey. A scholar is included among the top collaborators of George L. Mulvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George L. Mulvey. George L. Mulvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BfpI, BfpJ, and BfpK Minor Pilins Are Important for the Function and Biogenesis of Bundle-Forming Pili Expressed by Enteropathogenic Escherichia coli 2015 ·Journal of Bacteriology ·(unknown),(unknown),(unknown),George L. Mulvey,(unknown),Michael S. Donnenberg,Glen D. Armstrong	9
2	The Crystal Structure of Shiga Toxin Type 2 with Bound Disaccharide Guides the Design of a Heterobifunctional Toxin Inhibitor 2013 ·Journal of Biological Chemistry ·(unknown),Yin Jiang,Pavel I. Kitov,George L. Mulvey,(unknown),Michael N.G. James,Glen D. Armstrong,David R. Bundle	23
3	Structure of Clostridium difficile PilJ Exhibits Unprecedented Divergence from Known Type IV Pilins 2013 ·Journal of Biological Chemistry ·Kurt H. Piepenbrink,(unknown),(unknown),George L. Mulvey,Greg A. Snyder,(unknown),Erik C. von Rosenvinge,Sebastian Günther,Glen D. Armstrong,Michael S. Donnenberg,Eric J. Sundberg	31
4	Virulence potential and adherence properties of Escherichia coli that produce CTX-M and NDM β-lactamases 2013 ·Journal of Medical Microbiology ·Gisele Peirano,George L. Mulvey,Glen D. Armstrong,Johann Pitout	28
5	Binding of Clostridium difficile toxins to human milk oligosaccharides 2011 ·Glycobiology ·Amr El-Hawiet,Elena N. Kitova,Pavel I. Kitov,(unknown),Kenneth Ng,George L. Mulvey,Tanis C. Dingle,Adam Szpacenko,Glen D. Armstrong,John S. Klassen	40
6	Lipopolysaccharide Renders Transgenic Mice Expressing Human Serum Amyloid P Component Sensitive to Shiga Toxin 2 2011 ·PLoS ONE ·Thomas P. Griener,(unknown),Romney M. Humphries,George L. Mulvey,Carmen Fuentealba,Robert E. W. Hancock,Glen D. Armstrong	11
7	N‐acetyllactosamine‐induced retraction of bundle‐forming pili regulates virulence‐associated gene expression in enteropathogenic Escherichia coli 2010 ·Molecular Microbiology ·Romney M. Humphries,Thomas P. Griener,Stefanie Vogt,George L. Mulvey,Tracy Raivio,Michael S. Donnenberg,Pavel I. Kitov,Michael G. Surette,Glen D. Armstrong	26
8	Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile 2008 ·Glycobiology ·Tanis C. Dingle,Sheena Wee,George L. Mulvey,Antonio Greco,Elena N. Kitova,Jun Sun,Sheng‐Xiang Lin,John S. Klassen,Monica M. Palcic,Kenneth Ng,Glen D. Armstrong	58
9	The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin 2007 ·Cellular Microbiology ·(unknown),(unknown),Thomas P. Griener,George L. Mulvey,John S. Klassen,Michael S. Donnenberg,Glen D. Armstrong	41
10	Affinities of Shiga toxins 1 and 2 for univalent and oligovalent Pk-trisaccharide analogs measured by electrospray ionization mass spectrometry 2007 ·Glycobiology ·Elena N. Kitova,Pavel I. Kitov,Eugenia Paszkiewicz,Jong‐Hwa Kim,George L. Mulvey,Glen D. Armstrong,David R. Bundle,John S. Klassen	34
11	An Entropically Efficient Supramolecular Inhibition Strategy for Shiga Toxins 2007 ·Angewandte Chemie International Edition ·Pavel I. Kitov,Tomasz Lipiński,Eugenia Paszkiewicz,(unknown),Joanna Sadowska,Gordon A. Grant,George L. Mulvey,Elena N. Kitova,John S. Klassen,Glen D. Armstrong,David R. Bundle	24
12	Differential binding of Shiga toxin 2 to human and murine neutrophils 2007 ·Journal of Medical Microbiology ·Thomas P. Griener,George L. Mulvey,Paola Marcato,Glen D. Armstrong	33
13	Human Serum Amyloid P Component Protects againstEscherichia coliO157:H7 Shiga Toxin 2 In Vivo: Therapeutic Implications for Hemolytic‐Uremic Syndrome 2006 ·The Journal of Infectious Diseases ·Glen D. Armstrong,George L. Mulvey,Paola Marcato,Thomas P. Griener,Melvyn Kahan,Glenys A. Tennent,Caroline Sabin,Henrik Chart,Mark B. Pepys	41
14	Basis for N-acetyllactosamine-mediated inhibition of enteropathogenic Escherichia coli localized adherence 2006 ·Journal of Medical Microbiology ·(unknown),Thomas P. Griener,George L. Mulvey,Pavel I. Kitov,O. P. Srivastava,Paola Marcato,Glen D. Armstrong	25
15	Serum Amyloid P Component Binding to Shiga Toxin 2 Requires Both A Subunit and B Pentamer 2003 ·Infection and Immunity ·Paola Marcato,(unknown),George L. Mulvey,Glen D. Armstrong	23
16	Assessment in Mice of the Therapeutic Potential of Tailored, Multivalent Shiga Toxin Carbohydrate Ligands 2003 ·The Journal of Infectious Diseases ·George L. Mulvey,Paola Marcato,Pavel I. Kitov,Joanna Sadowska,David R. Bundle,Glen D. Armstrong	110
17	Glycan mimicry as a basis for novel anti-infective drugs 2001 ·Biochimie ·George L. Mulvey,Pavel I. Kitov,Paola Marcato,David R. Bundle,Glen D. Armstrong	43
18	Immunoprophylactic Potential of Cloned Shiga Toxin 2 B Subunit 2001 ·The Journal of Infectious Diseases ·Paola Marcato,George L. Mulvey,Randy J. Read,(unknown),Patrick N. Nation,Glen D. Armstrong	65
19	Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligandsbreakdown → 2000 ·Nature ·Pavel I. Kitov,Joanna Sadowska,George L. Mulvey,Glen D. Armstrong,Hong Ling,N.S. Pannu,Randy J. Read,David R. Bundle	713
20	Oleic acid uptake into rat and rabbit jejunal brush border membrane 1995 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown),M. Keelan,George L. Mulvey,Wolfgang Stremmel,A. B. R. Thomson	28

About George L. Mulvey

George L. Mulvey is a scholar working on Endocrinology, Infectious Diseases and Molecular Medicine, having authored 42 papers that have together received 2.3k indexed citations. Recurring topics across this work include Escherichia coli research studies (28 papers), Viral gastroenteritis research and epidemiology (14 papers) and Clostridium difficile and Clostridium perfringens research (13 papers). The work is most often cited by research in Endocrinology (687 citations), Infectious Diseases (717 citations) and Molecular Medicine (101 citations). George L. Mulvey has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Glen D. Armstrong, Pavel I. Kitov, David R. Bundle, Joanna Sadowska, Randy J. Read, Hong Ling, N.S. Pannu, Paola Marcato, Robert W. Hutkins and Tanis C. Dingle. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact